Antimicrobial Wound Care Dressings Market Size, Share, Growth, Trends | Report 2023-2032
The global antimicrobial wound care dressings market size was estimated at around USD 1.34 billion in 2022 and it is projected to hit around USD 2.5 billion by 2032, growing at a CAGR of 6.42% from 2023 to 2032.
Key Pointers
Report Scope of the Antimicrobial Wound Care Dressings Market
| Report Coverage | Details |
| Market Size in 2022 | USD 1.34 billion |
| Revenue Forecast by 2032 | USD 2.5 billion |
| Growth rate from 2023 to 2032 | CAGR of 6.42% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Convatec, Inc., B. Braun SE, 3M, Smith & Nephew; Cardinal Health; Coloplast Corp.; Paul Hartmann AG, Medline Industries; McKesson Corporation; Mölnlycke Health Care AB |
Antimicrobial wound care dressings are specialized wound dressings that contain agents or substances that help to prevent or treat infections in wounds. These dressings are designed to provide a barrier against bacteria, viruses, fungi, and other microorganisms that may enter the wound and cause infection. Increasing incidence of chronic and acute wounds, growing geriatric population, rise in number of surgical cases and traumatic wounds is expected to drive the market.
The increasing incidence of chronic wounds is one of the key drivers for the antimicrobial wound care dressings market. Antimicrobial wound care dressings contain agents or substances that have antimicrobial properties, such as silver, iodine, and PHMB. By providing a barrier against microorganisms, antimicrobial wound care dressings can reduce the risk of infection and promote healing. As the incidence of chronic wounds continues to rise globally, the demand for antimicrobial wound care dressings is expected to grow. For instance, as per ResearchGate, more than 13 million people globally experience chronic wounds every year. These dressings are particularly useful in the treatment of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, which are at high risk of infection. Therefore, increasing number of chronic wounds is anticipated to drive the antimicrobial wound care market.
The growing geriatric population is another important factors which drives the antimicrobial wound care dressings market. For instance, according to WHO, as of 2019, the number of people aged above 60 was more than 1 billion. Moreover, as per similar source, by 2030, one every six people globally will be aged more than 60. The incidence of chronic wounds, such as pressure ulcers and venous leg ulcers, increases with increasing elder population. Older adults are more susceptible to chronic wounds due to a variety of factors, including reduced mobility, impaired circulation, and comorbidities such as diabetes and cardiovascular disease. Therefore, increasing the use of antimicrobial wound care dressings.
Rising surgical procedures is further is expected to increase the demand for antimicrobial wound care dressings during the forecast period. Surgical wounds are at risk of infection, and antimicrobial wound care dressings can help to prevent or treat these infections, promoting faster healing and reducing the risk of complications. Further surgical cite infections (SII) are infections that patients acquire while receiving treatment in a healthcare setting during or after a surgery. These infections can be caused by a variety of microorganisms, including bacteria, viruses, and fungi. The occurrence of SII is a major concern for healthcare providers and patients alike. Antimicrobial wound care dressings can be used in various surgical procedures, such as orthopedic, cardiovascular, and plastic surgeries, to reduce the risk of infection and promote faster healing. Thus, driving the market growth.
Antimicrobial Wound Care Dressings Market Segmentations:
By Product
By Application
By End-use
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Product Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Antimicrobial Wound Care Dressings Market
5.1. COVID-19 Landscape: Antimicrobial Wound Care Dressings Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Antimicrobial Wound Care Dressings Market, By Product
8.1. Antimicrobial Wound Care Dressings Market, by Product, 2023-2032
8.1.1 Silver Dressings
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Povidone-iodine Dressings
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. PHMB Dressings
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Antimicrobial Wound Care Dressings Market, By Application
9.1. Antimicrobial Wound Care Dressings Market, by Application, 2023-2032
9.1.1. Chronic Wounds
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Acute Wounds
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Antimicrobial Wound Care Dressings Market, By End-use
10.1. Antimicrobial Wound Care Dressings Market, by End-use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Outpatient Facilities
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Home Care
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Research & Manufacturing
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Antimicrobial Wound Care Dressings Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 12. Company Profiles
12.1. Convatec, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. B. Braun SE
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. 3M
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Smith & Nephew
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cardinal Health
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Coloplast Corp.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Paul Hartmann AG
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medline Industries
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. McKesson Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Mölnlycke Health Care AB
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers